Drugs / Clostridium difficile toxoids A and B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01230957 | Oct 2010 → Nov 2012 | Clostridium difficile colitis, diarrheal disease | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clostridium difficile toxoids A and B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01230957 ↗ |
| Modality | Vaccine | “candidate toxoid vaccine against C. difficile toxins A and B” PMID 27013431 ↗ Mar 2016 |
| Route | Intramuscular | “Administration was intramuscular.” PMID 27013431 ↗ Mar 2016 |